Guillain Barre Syndrome following Precautionary dose of vaccine against COVID 19: A rare occurrence

  • M A Beg Department of Pharmacology, SGRRIM&HS, Patel Nagar, Dehradun-248001
Keywords: COVID-19 vaccine, Guillain Barre Syndrome

Abstract

SARS CoV2 first appeared in Wuhan, China in Dec 2019 and soon spread across the world at a rapid pace and was declared as Pandemic in March 2020.The spectrum of disease caused by COVID19 ranges from mild to severe illness with predominant respiratory symptoms and can progress to Acute Respiratory Distress Syndrome, Multiorgan failure and death. The present case is related to the occurrence of Guillain Barre Syndrome following the precautionary dose of vaccine against COVID 19.

Published
2022-09-09
Section
CASE REPORT